Cardiometabolic Impact of a Produce Prescription Program in Patients With Type 2 Diabetes and Food Insecurity

{ "Produce Prescription Program for Type 2 Diabetes and Food Insecurity", "This study is looking at whether providing monthly gift cards for fruits and vegetables, along with dietary education, can help adults with type 2 diabetes better manage their blood sugar. You might be able to join if you have type 2 diabetes, your most recent HbA1c (a measure of average blood sugar over 2-3 months) was above 8%, and you are experiencing food insecurity (difficulty affording enough food). The study aims to see if this program can lower HbA1c levels over 5 and 10 months. The study is currently unclear on its recruitment status and plans to enroll 88 people.", "design": "This is an interventional study where participants will be randomly assigned to one of two groups. One group receives a produce gift card and dietary education, while the other receives usual care.", "commitments": "Participants in one group will receive monthly produce gift cards and dietary education for 5 months, followed by 5 months of usual diabetes care. Blood sugar levels (HbA1c) will be measured at the beginning, at 5 months, and at 10 months.", "compensation": "Not stated in the trial record.", "follow_up": "Participants' blood sugar levels will be followed for 10 months after the start of the study.", }

Study design
Not specified.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07674979

Cardiometabolic Impact of a Produce Prescription Program in Patients With Type 2 Diabetes and Food Insecurity

Enrolling by Invitation
NAAges 18+InterventionalTreatment
West Virginia University
~88 participants
Updated 2026-08-17 on ClinicalTrials.gov
What's tested:Produce Gift Card and Dietary EducationUsual Care

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Hemoglobin A1c from Baseline to 5 Months
Measured over Baseline and 5 months
+1 more outcome measured
Type 2 Diabetes

NCT07674979

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • West Virginia University Heart and Vascular Institute

    Morgantown, West Virginiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • George Sokos, DO, FACC · PRINCIPAL_INVESTIGATOR · West Virginia University Heart and Vascular Institute

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of type 2 diabetes mellitus
Most recent HbA1c \>8% within the prior 6 months
Must have had a clinic visit within the past 6 months
Positive screening for food insecurity based on the USDA 6-item food security survey
Receiving care through WVU cardiometabolic, endocrinology, or primary care clinics
Able and willing to provide written informed consent

Exclusion

End-stage renal disease
Advanced heart failure
Severe cognitive impairment
Chronic pancreatitis
Pancreatic malignancy
Pregnancy at time of enrollment
Anticipated inability to utilize intervention vouchers (e.g., lack of access to Walmart)
  • Change in Hemoglobin A1c from Baseline to 5 MonthsBaseline and 5 months

    Change in hemoglobin A1c (%) measured using a standard laboratory test at baseline and at the 5-month study visit. Hemoglobin A1c reflects average blood glucose over the prior 2 to 3 months. The outcome measure is the change in hemoglobin A1c from baseline to 5 months and will be evaluated according to randomized treatment sequence and study period.

  • Change in Hemoglobin A1c from Baseline to 10 MonthsBaseline and 10 months

    Change in hemoglobin A1c (%) measured using a standard laboratory test at baseline and at the 10-month study visit. Hemoglobin A1c reflects average blood glucose over the prior 2 to 3 months. The outcome measure is the change in hemoglobin A1c from baseline to 10 months and will be evaluated according to randomized treatment sequence and study period